Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Long intergenic non-coding RNA 00324 promotes gastric cancer cell proliferation via binding with HuR and stabilizing FAM83B expression.

Zou Z, Ma T, He X, Zhou J, Ma H, Xie M, Liu Y, Lu D, Di S, Zhang Z.

Cell Death Dis. 2018 Jun 18;9(7):717. doi: 10.1038/s41419-018-0758-8.

2.

Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1.

Wang H, Chen Y, Guo J, Shan T, Deng K, Chen J, Cai L, Zhou H, Zhao Q, Jin S, Xia J.

Sci Rep. 2018 May 4;8(1):7080. doi: 10.1038/s41598-018-25443-3.

3.

Novel microtubule inhibitor MPT0B098 inhibits hypoxia-induced epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.

Tsai IT, Kuo CC, Liou JP, Chang JY.

J Biomed Sci. 2018 Mar 28;25(1):28. doi: 10.1186/s12929-018-0432-6.

4.

Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy.

Toyota K, Murakami Y, Kondo N, Uemura K, Nakagawa N, Takahashi S, Sueda T.

Ann Surg Oncol. 2018 May;25(5):1202-1210. doi: 10.1245/s10434-018-6392-y. Epub 2018 Feb 28.

PMID:
29492748
5.

MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR).

Al-Haidari A, Algaber A, Madhi R, Syk I, Thorlacius H.

Cancer Lett. 2018 May 1;421:145-151. doi: 10.1016/j.canlet.2018.02.026. Epub 2018 Feb 20.

PMID:
29471005
6.

HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis.

Qian L, Ji AH, Zhang WJ, Zhao N.

Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):430-442. doi: 10.26355/eurrev_201801_14192.

7.

Functional Role of a Novel Long Noncoding RNA TTN-AS1 in Esophageal Squamous Cell Carcinoma Progression and Metastasis.

Lin C, Zhang S, Wang Y, Wang Y, Nice E, Guo C, Zhang E, Yu L, Li M, Liu C, Hu L, Hao J, Qi W, Xu H.

Clin Cancer Res. 2018 Jan 15;24(2):486-498. doi: 10.1158/1078-0432.CCR-17-1851. Epub 2017 Nov 3.

PMID:
29101304
8.

Adrenaline promotes epithelial-to-mesenchymal transition via HuR-TGFβ regulatory axis in pancreatic cancer cells and the implication in cancer prognosis.

Pu J, Zhang X, Luo H, Xu L, Lu X, Lu J.

Biochem Biophys Res Commun. 2017 Nov 25;493(3):1273-1279. doi: 10.1016/j.bbrc.2017.09.146. Epub 2017 Sep 28.

PMID:
28965949
9.

CRABP-II enhances pancreatic cancer cell migration and invasion by stabilizing interleukin 8 expression.

Yu S, Parameswaran N, Li M, Wang Y, Jackson MW, Liu H, Xin W, Zhou L.

Oncotarget. 2016 Dec 26;8(32):52432-52444. doi: 10.18632/oncotarget.14194. eCollection 2017 Aug 8.

10.

Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis.

Lee SK, Park KK, Kim HJ, Park J, Son SH, Kim KR, Chung WY.

Sci Rep. 2017 Aug 29;7(1):9610. doi: 10.1038/s41598-017-09040-4.

11.

The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors.

Brauß TF, Winslow S, Lampe S, Scholz A, Weigert A, Dehne N, von Stedingk K, Schmid T, Brüne B.

Mol Carcinog. 2017 Dec;56(12):2620-2629. doi: 10.1002/mc.22706. Epub 2017 Jul 28.

PMID:
28731284
12.

Downregulation of HuR Inhibits the Progression of Esophageal Cancer through Interleukin-18.

Xu X, Song C, Chen Z, Yu C, Wang Y, Tang Y, Luo J.

Cancer Res Treat. 2018 Jan;50(1):71-87. doi: 10.4143/crt.2017.013. Epub 2017 Feb 24.

13.

Eotaxin-2 increased toll-like receptor 4 expression in endothelial cells in vitro and exacerbates high-cholesterol diet-induced atherogenesis in vivo.

Tsai CS, Huang CY, Chen CH, Lin YW, Shih CM, Tsao NW, Chiang KH, Lee CY, Jeng H, Lin FY.

Am J Transl Res. 2016 Dec 15;8(12):5338-5353. eCollection 2016.

14.

Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of γ-synuclein in hepatocellular carcinoma cells.

He X, Zheng Y, Zhang Y, Gan Y, Zhou Y, Liang H, Wu D, Ge W, Deng J, Xu X.

Oncotarget. 2017 Feb 7;8(6):9451-9465. doi: 10.18632/oncotarget.14276.

15.
16.

Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment.

Kotta-Loizou I, Vasilopoulos SN, Coutts RH, Theocharis S.

Neoplasia. 2016 Nov;18(11):674-688. doi: 10.1016/j.neo.2016.09.002. Epub 2016 Oct 18. Review.

17.

Dysregulation of TTP and HuR plays an important role in cancers.

Wang H, Ding N, Guo J, Xia J, Ruan Y.

Tumour Biol. 2016 Nov;37(11):14451-14461. Epub 2016 Sep 19. Review.

PMID:
27644249
18.

Long Noncoding RNA MALAT1 Promotes Aggressive Pancreatic Cancer Proliferation and Metastasis via the Stimulation of Autophagy.

Li L, Chen H, Gao Y, Wang YW, Zhang GQ, Pan SH, Ji L, Kong R, Wang G, Jia YH, Bai XW, Sun B.

Mol Cancer Ther. 2016 Sep;15(9):2232-43. doi: 10.1158/1535-7163.MCT-16-0008. Epub 2016 Jul 1.

19.

HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors.

Leijon H, Salmenkivi K, Heiskanen I, Hagström J, Louhimo J, Heikkilä P, Ristimäki A, Paavonen T, Metso S, Mäenpää H, Haglund C, Arola J.

APMIS. 2016 Sep;124(9):757-63. doi: 10.1111/apm.12571. Epub 2016 Jun 30.

PMID:
27357268
20.

The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer.

Latorre E, Carelli S, Raimondi I, D'Agostino V, Castiglioni I, Zucal C, Moro G, Luciani A, Ghilardi G, Monti E, Inga A, Di Giulio AM, Gorio A, Provenzani A.

Cancer Res. 2016 May 1;76(9):2626-36. doi: 10.1158/0008-5472.CAN-15-2018. Epub 2016 Apr 20.

Supplemental Content

Loading ...
Support Center